BioScience Trends. 2023;17(1):1-13. (DOI: 10.5582/bst.2023.01013)
The initiation, exploration, and development of hospital-based health technology assessment in China: 2005 ‒ 2022
Tang M, Zhang XY, Ye ZP, Feng LF, Yang Y, Hou ZY, Bai F, Lin X, Liu XY, Yang H, Hu SL, Song PP, He JJ
A hospital-based health technology assessment (HB-HTA) can provide the evidence needed to inform clinical decisions at the administrative level. With the implementation of a new round of medical and health care system reforms in China, such as the abolition of medical mark-ups, adoption of modern hospital management systems, reform of diagnosis related groups (DRGs) payment, and performance evaluations for public hospitals, medical institutions increasingly need HB-HTA. The development of HB-HTA in China can be divided into three phases: An initiation phase (2005–2014), a preliminary exploratory phase (2015–2017), and a rapid development phase (2018–present). HB-HTA has been used to manage medical consumables, medical devices, and medicines, but there are still problems and challenges in terms of concept recognition, the mode of development, and limited professionals and data. To promote and use HB-HTA in developing countries, we have identifies the development paths and recommendations for implementation based on a case study in China, which can be summarized as follows: enhancing the top-level design of HB-HTA, formulating HB-HTA guidelines, further promoting the main ideas of HB-HTA, concentrating on the training of evaluation personnel, establishing an HB-HTA network and paying attention to the flexibility of HB-HTA in the application process, and multi- stakeholder participation.
Full Text: 
